CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CANbridge Pharmaceuticals Inc. has announced the appointment of Dr. Fangxin Li as a non-executive Director and a member of the remuneration committee, effective September 30, 2024. Concurrently, Mr. Edward Hu will resign from his non-executive Director position and as a member of the same committee. The changes come as part of a board and committee reorganization to strengthen the company’s governance and strategic direction.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.